Thu, January 28, 2021

David Lewis Maintained (ABT) at Buy with Increased Target to $136 on, Jan 28th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-136-on-jan-28th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
David Lewis of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $126 to $136 on, Jan 28th, 2021.

David has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $122 on, Thursday, October 22nd, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $120 on, Wednesday, October 21st, 2020
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020